Immunovative’s technology has the potential to forever change the manner in which we treat cancer and infectious disease. Rather than use harsh and toxic chemicals or try to interfere with natural processes of cell growth and viral control, Immunovative harnesses the natural power of the immune system to create powerful, non-toxic new therapy approaches. Immunovative’s technology platform is called the “Mirror EffectTM”. This innovative platform is modeled from knowledge of an immune mechanism already proven be capable of eliminating chemotherapy-resistant metastatic tumors and the HIV virus. Unfortunately, the clinical application of this known mechanism is limited because it is associated with severe, often lethal, toxicity. Our innovation was to develop a way to harness the proven curative effects of this mechanism and eliminate the toxicity. This accomplishment positions us to provide new innovative immunotherapy products with unprecedented effects in late stage cancer and HIV positive patients. Our technology platform is well protected by patents worldwide which position us to become a leader in the development and commercialization of immunotherapy products.